Contact UsCareersNewsScienceContact Us
News & Media

Discover our presence in global media here

HomeNewsPRESS RELEASES

2023

January 5, 2023
Pfizer Announces 12-Week Paternity Leave Policy for its Employees

2022

December 16, 2022
Pfizer Launches ‘Pfizer PAP India’, an assistance app for Indian patients
December 15, 2022
Pfizer launches Project Aastha Cancer-Care Services and Helpdesk at Sawai Man Singh Hospital, Jaipur
October 19, 2022
Pfizer India, Americares India, Trained Nurses Association of India partner to expand reach of Online Learning Programme on Antimicrobial Resistance, OPEN-AMR for Nurses
September 26, 2022
Pfizer India partners with Father Muller Research to strengthen evidence generation and encourage young researchers
September 12, 2022
Six start-ups in Oncology and Digital Health to receive grants of 65 lacs each under Pfizer’s INDovation Program
July 15, 2022
Pfizer India partners with Max Super Speciality Hospitals to strengthen evidence generation and encourage young researchers
June 13, 2022
Pfizer launches India’s first free of cost Online Education Platform on AMR in regional languages for Nurses
May 4, 2022
Pfizer sets up global drug development center in India
April 5, 2022
INDovation program to incubate and commercialise Indian healthcare start-ups launched
March 30, 2022
Pfizer launches Project Aastha Cancer-Care Services and Helpdesk at The Gujarat Cancer & Research Institute, Ahmedabad
March 10, 2022
Pfizer launches its 6th helpdesk in cancer hospitals in India
March 7, 2022
Pfizer launches Project Aastha Cancer-Care Services and Helpdesk at the Regional Cancer Center in Raipur
February 21, 2022
Pfizer’s support to Tata Trusts Cancer Care Programme helps enroll and screen close to 70,000 people for NCDs and Cancer within a year
February 7, 2022
Mr. Pradip Shah appointed as Chairman of Pfizer Limited Board

VIEW ALL

PFIZER IN NEWS

2023

Pfizer offers 12-week paternity leave

The Times of India- (Jan 6)

As a part of its diversity and inclusion initiatives, Pfizer India announced its 12-week paternity leave policy for its employees. The new leave policy, effective from 1st January 2023, can be availed by biological as well as adoptive fathers. The introduction of a 12-week paternity leave for the employees will significantly influence the ongoing momentum on the employee-focused initiatives at Pfizer. Read more

Eduroam network facility at GITAM

The Hans- (Jan 4)

In collaboration with Gandhi Institute of Technology and Management (GITAM) University, Pfizer Healthcare India Private Limited (PHIPL) onboards over 120 female students in its second batch of ‘Pfizer Autonomous Teams’ (PATs) Program. The work-integrated learning program will enable these female students to become future-ready to make a career in pharma/biotech industry while they pursue their bachelor's degree education. Read more

2022

Pfizer India launches app to ease, fast-track enrollment to its patient access programmes

ET Healthworld - (Dec 16)

Pfizer India launches an app to ease and fast-track enrollment to its patient access programmes (PAP)  to broaden access to Pfizer's innovative drugs to patients. The mobile application, available on iOS and Android platforms, is designed to support patients who want to participate in Pfizer's Patient Access Programs based on the valid prescription provided by their treating physician. Read more

Pfizer launches Project Aastha Cancer-Care Services and Helpdesk at Sawai Man Singh Hospital, Jaipur

Business News Week - (Dec 15)

Pfizer Limited has launched its 13th Aastha helpdesk at one of the biggest government hospitals in Jaipur, the Sawai Man Singh Hospital (SMS) that caters to over 10,000 patients daily. The newest helpdesk has been set up with an aim to further India’s vision of accessible healthcare for all. Pfizer aims to establish close to 20 such helpdesks across various states in India. The Aastha Cancer-Care helpdesk marks a step towards creating an ecosystem where patients get the care, support, and empathy they need. Read more

Developing Innovative Delivery Systems And Advancing Go-To-Market Models In Pharma

Industry Outlook- (Dec 14)

In conversation with Industry Outlook, Mr. Aninda Shome, Director-Global Supply Chain, Pfizer India shares his views on the pharmaceutical Supply Chain. During the conversation, he throws light on the issues pertaining to On-time in-full (OTIF) delivery, optimizing inventory levels and more. Mr Aninda Shome also discusses about data-driven demand forecasting and planning increasingly becoming a key factor for logistics planning in Supply Chain. Read more

Lessons from Covid: Pharma firms turn attention to adult vaccination

Business Standard- (Dec 5)

Post-pandemic, Pharma companies have now turned their focus to adult-vaccination for infections caused by Pneumonia, flu, shingles, to name a few. Demand for pneumonia vaccines for adults has shot up during the last two years. Pfizer has helped set up over 150 vaccination centers in hospitals across India to drive scientific conversations around vaccines and provide an opportunity to immunize the vulnerable population—Pfizer India country president S Sridhar was prominently quoted saying. Read more

Pfizer India inks partnership with Father Muller Research to award fellowships to younger scientists

MSN - (Sep 26)

Biopharmaceutical major Pfizer India on Monday announced that it has signed a Memorandum of Understanding (MoU) with Father Muller Research to give fellowship opportunities to young researchers for gathering real-world evidence on drug efficacy and proven therapies from existing Electronic Patient records. Read more

Pfizer India partners with Father Muller Research to strengthen evidence generation in cancer and CVDs

The Economic Times - (Sep 26)

The aim of the partnership is to enhance scope of care and create avenues for new research. Researchers will access existing electronic health record to develop a deeper understanding on drug efficacy in proven therapies. It will focus on evidence generation on prevention, treatment and management of diseases such as cancer and cardiovascular diseases. Read more

Six start-ups in Oncology and Digital Health to receive grants of 65 lacs each under Pfizer's INDovation Program 

The Economic Times - (Sep 15)

Program supported by Pfizer Limited (“Pfizer”), Atal Innovation Mission (AIM), NITI Aayog, Social Alpha, Foundation for Innovation and Technology Transfer (FITT), IIT-Delhi and AGNIi; with UN Health Innovation Exchange (UNHIEX) as knowledge partner. Customised incubation support across technology incubation centers like the IITs and other major technology institutes across India; grant upto Rs. 65 lacs per selected start-up. Read more

Hyderabad startup gets Pfizer grant 

Times Of India - (Sep 14)

City-based Oncophenomics Life Sciences has received a grant of 65 lakh under Pfizer's incubation programme. Read more

Start-ups Receive Grants Of 65 Lacs Each Under Pfizer’s INDovation Program

BW Healthcare World - (Sep 13)

The six winners who will be given a grant of Rs. 65 lacs each will receive incubation support from AIM, NITI Aayog and IIT Delhi. Pfizer will provide the grant as well as mentorship and technical assistance to the start-ups and Social Alpha will provide program acceleration support. Read more

Six health start-ups to get Rs 65 lakhs each under Pfizer's INDovation programme

Money Control - (Sep 12)

Pfizer will provide the grant as well as mentorship and technical assistance to the six winning health start-ups while its programme partner Social Alpha will provide the programme acceleration support. Read more

Disseminating bottom-up approach to AMR is a necessity

The Economic Times - (Aug 5)

A country with one of the heaviest burdens of infectious diseases and drug-resis tant pathogens, while also being a country renowned for the prowess of its pharmaceuticals industry, quality of science and innovative public and academic instiutions, there is no reason why the next global breakthrough anti-infective drug should not come from India. Read more

Pfizer India, Max Hospitals join hands to promote research on drug efficacy

Money Control - (Jul 15)

The research will focus on prevention, treatment and management of diseases that are of public health priority in India such as cancer and cardiovascular diseases. Read more

Pfizer India, Max Hospitals sign MoU for fellowship programme

The Economic Times - (Jul 15)

The aim of the partnership is to enhance scope of care and create avenues for new research. Researchers will access existing Electronic Health Record to develop a deeper understanding on drug efficacy in proven therapies. Read more

How Digitalization Is Transforming the World of Healthcare

The Economic Times - (Jul 12)

This digital transformation is not only going to revolutionize the market model, but also the mindset and approach of patients and healthcare professionals alike. Read more

From AstraZeneca to Pfizer, Big Pharma is banking on India’s data and IT chops for cutting-edge R&D

The Economic Times - (Jun 24)

When a deadly virus had the world in its grip two years ago, scientists were faced with an uphill task of finding a vaccine and fast. Read more

Hike in cash aid for patients with rare diseases raises hopes for entry of new ‘orphan drugs’ in India

Money Control - (Jun 7)

The change has come through a modification in the National Policy for Rare Diseases, which was first notified in 2021. Read more

Pfizer’s 1st drug development lab in Asia opens in Chennai

The Economic Times - (May 5)

US pharmaceutical company Pfizer has set up its global drug development centre at the Indian Institute of Technology-Madras Research Park here, at an outlay of over Rs 150 crore. Read more

Pfizer makes big R&D push in India

Mint - (May 5)

The 61,000 sq. ft centre, built at $20 million, will be part of a network of 12 Pfizer global centres. Read more

Pfizer Sets Up Asia's First Global Drug Development Centre In Chennai

NDTV - (May 4)

Pfizer has invested USD 20 million (INR 150 crore) in the 61,000 sq ft research and technology centre at the IIT Madras Research Park. Read more

Pfizer sets up global drug development centre in India

India Today - (May 4)

Pfizer has set up a centre to develop APIs and finished dosage forms of differentiated products for global markets, at the IIT Madras Research Park campus in Chennai. Read more

Pfizer Indovation Program To Back Oncology, Healthcare Startups In India | StartUp Central

Times Now - (Apr 9)

Pfizer launches the Pfizer INDovation Program to back Oncology, Healthcare Startups in India. It will grant Rs 65 lakh to each of the three winning startups. Read more

Pfizer offers voluntary retirement scheme for field staff

PTI News - (Apr 7)

Drug firm Pfizer Ltd on Thursday offered a voluntary retirement scheme (VRS) for its field staff as part of expanding its digital capabilities and revamping talent strategy. Read more

Seven organisations come together to launch INDovation programme to incubate and commercialise Indian healthcare startups

Express Pharma - (Apr 6)

The programme is supported by Pfizer, Atal Innovation Mission (AIM), NITI Aayog, Social Alpha, Foundation for Innovation and Technology Transfer (FITT), IIT-Delhi and AGNIi; with UN Health Innovation Exchange (UNHIEX) as knowledge partner. Read more

Pfizer to back startups in India working on oncology, digital health

The Economics Times - (Apr 6)

Pfizer will provide grants of up to Rs 65 lakh and two years of incubation support through the Indian Institutes of Technology (IITs) and other top academic institutions to six startups, starting with three in the first year. Read more

Pfizer launches Project Aastha helpdesk at RCC, Pandit Jawaharlal Nehru Memorial Medical College, Raipur

The Economic Times- (Mar 10)

The helpdesk, set up in the R block of the hospital, will support patients with support patients with registration; travel booking information and support; local accommodation guidance and linkages among other services. Read more

Pfizer’s support to Tata Trusts Cancer Care programme

Indian Express - (Feb 23)

Pfizer has announced that its support to Tata Trusts Cancer Care programme since 2020 has helped in enrolling and screening 70,000 people for non-communicable diseases (NCDs) and cancer across Assam, Jharkhand and Andhra Pradesh. Read more

Pfizer supports Tata Trusts Cancer Care Programme

The Pioneer - (Feb 22)

Pfizer today announced that its support to Tata Trusts Cancer Care programme since 2020 has helped in enrolling and screening 70,000 people for non-communicable diseases (NCDs) and Cancer across Assam, Jharkhand and Andhra Pradesh. Read more

Pradip Shah appointed Pfizer India chairman

Times Of India - (Feb 7)

Pfizer India on Monday appointed Pradip Shah as the chairman of its board following the resignation  of R A Shah on February 3. Read more

Pradip Shah elevated as Chairman of the Board of Pfizer Limited

The Economic Times - (Feb 7)

Shah has been on the Board of Pfizer since December 1999 and has been guiding the Board and Management on various financial and strategic decisions. Read more

VIEW ALL

Media Contacts

This information is intended for media professionals only. To ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may ONLY respond to calls and emails from professional journalists.

Email us at: Contactus.India@Pfizer.com
Call us at: +91 - 022 - 6693 2000

If you are not a journalist, please visit Contact Us to reach the appropriate Pfizer contact.

  • COMPANY FACT SHEET
  • LOGOS
  • VALUES
  • CSR
  • COMPANY HISTORY
About UsOur ScienceOur Community EffortsYour Health Career-Seekers News & MediaHealthcare ProfessionalsContact UsTerms And ConditionsPrivacy PolicyAdverse Event ReportingCopyright © 2002- 2022 Pfizer Inc. All rights reserved. This information—including product information—is intended only for residents of  India and strictly only for informational, educational, academic and/or research purposes and is not intended to substitute for professional medical advice, diagnosis or treatment. While due care and caution has been taken to ensure that the content here is free from mistakes or omissions, Pfizer makes no claims, promises or guarantees about the accuracy, completeness or adequacy of the information here. You may report an adverse event related to Pfizer products by emailing us at IND.AEReporting@pfizer.com or via Fax at: 000800100-5961 / +91-22 3919-771.